ASTH (Astrana Health) FFO


ASTH Astrana Health Inc ASTH
87 GF Score
Price $43.48
GF Value $82.34
Valuation Significantly Undervalued
! 8 Warning Signs
View Full Analysis

What is Astrana Health FFO?

FFO (Funds from operations) only applies to REITs.

ASTH
87GF Score
Astrana Health Inc ASTH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $43.48 is trading 47.2% below its estimated GF Value™ of $82.34. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

  • FFO:
  • GF Value™: $82.34 vs. price of $43.48 (47.2% below fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astrana Health Business Description

Other Exchanges 3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score

Get the complete analysis for ASTH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.48
Price
$82.34
GF Value